Functional brain imaging and mood disorders with treatment

被引:0
|
作者
Baux, P
Thomas, P
Dutoit, D
Vaiva, G
Goudemand, M
Lecouffe, P
Laury, C
Steinling, M
机构
[1] CHRU LILLE,SERV PSYCHIAT GEN,UNITES SOINS NORMALISES B,F-59037 LILLE,FRANCE
[2] CHRU LILLE,SCMN HOP B,UNITE IMAGERIE FONCTIONNELLE CEREBRALE,F-59037 LILLE,FRANCE
来源
CIRCULATION ET METABOLISME DU CERVEAU | 1995年 / 12卷 / 04期
关键词
depression; cerebral blood flow; HMPAO Tc-99m; treatment responsiveness;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using single photon emission computed tomography (SPECT) brain imaging with the HMPAO Tc-99m perfusion technique, Rie measured the variations of HMPAO uptake ratios before and after 5 weeks treatement in 26 unipolar depressive patients meeting the diagnostic criteria of major depressive disorder according to the DSMIII-r. The aim of this study was to compare for these patients changes in brain HMPAO uptake according to antidepressant responsivness in major depression. After the second assessment, they were divided in 3 groups according to clinical improvment rated with MADRS and BECK : group A, n = 8 good response (MADRS and BECK < 8); group B, n = 9 partial response (9 < MADRS and BECK < 14); group C, n = 9 unsatisfying response (MADRS and BECK > 15). Between two exams, the data analysis showed increase HMPAO fixation ratio, in anterior cerebral regions in group A, in median and posterior regions in groupe B. No variation HMPAO uptake was noted in group C. Initial measures of HMPAO uptake indexes in right lateral frontal and occipital regions and variation indexes after treatment permitted to differentiate group. Regarding prognosis preoccupations, pre-treatment SPECT pattern may also be useful to consider treatement responsiveness.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [41] Functional imaging in treatment planning of brain lesions
    Hamilton, RJ
    Sweeney, PJ
    Pelizzari, CA
    Yetkin, FZ
    Holman, BL
    Garada, B
    Weichselbaum, RR
    Chen, GTY
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (01): : 181 - 188
  • [42] FUTURE TREATMENT OF MOOD DISORDERS
    Young, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 4 - 4
  • [43] Cannabidiol in the Treatment of Mood Disorders
    Pinto J.V.
    Ziak M.L.
    Schaffer A.
    Yatham L.N.
    Current Treatment Options in Psychiatry, 2022, 9 (3) : 140 - 150
  • [44] Treatment resistant mood disorders
    Ng, C
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2002, 36 (04): : 570 - 571
  • [45] INPATIENT TREATMENT OF MOOD DISORDERS
    MENDELBERG, HE
    PSYCHOLOGICAL REPORTS, 1995, 76 (03) : 819 - 824
  • [46] LITHIUM IN THE TREATMENT OF MOOD DISORDERS
    PRICE, LH
    HENINGER, GR
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09): : 591 - 598
  • [47] Adherence to treatment in mood disorders
    Byrne, N
    Regan, C
    Livingston, G
    CURRENT OPINION IN PSYCHIATRY, 2006, 19 (01) : 44 - 49
  • [48] The Treatment of Preschool Mood Disorders
    DeFilippis M.
    Wagner K.D.
    Current Treatment Options in Psychiatry, 2015, 2 (1) : 57 - 72
  • [49] What is the relevance of the term "functional" in psychiatric disorders in the era of functional brain imaging?
    Manjunatha, Narayana
    Roopa, G.
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2010, 47 (02): : 62 - 63
  • [50] Ketamine Treatment for Mood Disorders
    Klise, Andrew
    Lerner, Brian
    Ettensohn, Marc F.
    Levine, Steven P.
    PSYCHIATRIC ANNALS, 2018, 48 (04) : 175 - 179